SYNTHESIS OF BENZIMIDAZOLES
2885
REFERENCES
1. (a) Erhardt, P. W. In search of the digitalis replacement. J. Med. Chem. 1987, 30, 231–237;
(b) Tomczuk, B. E.; Taylor Jr., C. R.; Moses, L. M.; Sutherland, D. B.; Lo, Y. S.;
Johnson, D. N.; Kinnier, W. B.; Kilpatrick, B. F. 2-Phenyl-3H-imidazo[4,5-b]pyridine-3-
acetamides as nonbenzodiazepine anticonvulsants and anxiolytics. J. Med. Chem. 1991,
34, 2993–3006; (c) Gravatt, G. L.; Baguley, B. C.; Wilson, W. R.; Denny, W. A.
DNA-directed alkylating agents, 6: Synthesis and antitumor activity of DNA minor
groove-targeted aniline mustard analogs of pibenzimol (Hoechst 33258). J. Med. Chem.
1994, 37, 4338–4345.
2. Kim, J. S.; Gatto, B.; Yu, C.; Liu, A.; Liu, L. F.; LaVoie, E. J. Substituted 2,50-bi-1H-
benzimidazoles: Topoisomerase I inhibition and cytotoxicity. J. Med. Chem. 1996, 39,
992–998.
3. Roth, T.; Morningstar, M. L.; Boyer, P. L.; Hughes, S. H.; Buckheit Jr., R. W.; Michejda,
C. J. Synthesis and biological activity of novel nonnucleoside inhibitors of HIV-1 reverse
transcriptase: 2-Aryl-substituted benzimidazoles. J. Med. Chem. 1997, 40, 4199–4207.
4. Wright, J. B. The chemistry of the benzimidazoles. Chem. Rev. 1951, 48, 397–541.
5. (a) Tidwell, R. R.; Geratz, J. D.; Dann, O.; Volz, G.; Zeh, D.; Loewe, H. Diarylamidine
derivatives with one or both of the aryl moieties consisting of an indole or indole-like ring:
Inhibitors of arginine-specific esteroproteases. J. Med. Chem. 1978, 21, 613–623; (b)
Fairley, T. A.; Tidwell, R. R.; Donkor, I.; Naiman, N. A.; Ohemeng, K. A.; Lombardy,
R. J.; Bentley, J. A.; Cory, M. Structure, DNA minor groove binding, and base pair speci-
ficity of alkyl- and aryl-linked bis(amidinobenzimidazoles) and bis(amidinoindoles). J.
Med. Chem. 1993, 36, 1746–1753.
6. Bourgrin, K.; Loupy, A.; Soufiaoui, M. Trois Nouvelles Voies de Synthesis des Derives 1,
3-Azoliques Sous Micro-ondes. Tetrahedron 1998, 54, 8055–8064.
7. Harapanhalli, R. S.; McLaughlin, L. W.; Howell, R. W.; Rao, D. V.; Adelstein, S. J.;
Kassis, A. I. [125I=127I]IodoHoechst 33342: Synthesis, DNA binding, and biodistribution.
J. Med. Chem. 1996, 39, 4804–4809.
8. Verner, E.; Katz, B. A.; Spencer, J. R.; Allen, D.; Hataye, J.; Hruzewicz, W.; Hui, H. C.;
Kolesnikov, A.; Li, Y.; Luong, C.; Martelli, A.; Radika, K.; Rai, R.; She, M.; Shrader,
W.; Sprengeler, P. A.; Trapp, S.; Wang, J.; Young, W. B.; Mackman, R. L. Development
˚
of serine protease inhibitors displaying a multicentered short (<2.3 A) hydrogen bond
binding mode: Inhibitors of urokinase-type plasminogen activator and factor Xa. J.
Med. Chem. 2001, 44, 2753–2771.
9. van den Eynde, J. J.; Delfosse, F.; Lor, P.; van Haverbeke, Y. A mild catalyst for the
formation of carbon–nitrogen bonds. Tetrahedron 1995, 51, 5813–5818.
10. Patzold, F.; Zeuner, F.; Heyer, T. H.; Niclas, H.-J. Dehydrogenations using benzofuroxan
as oxidant. Synth. Commun. 1992, 22, 281–284.
11. Bhatnagar, I.; George, M. V. Development of new and efficient polymer-supported
hypervalent iodine reagents. Tetrahedron 1968, 24, 1293–1296.
12. Stephens, F. F.; Bower, J. D. One-step high-throughput synthesis of benzimidazoles. J.
Chem. Soc. 1949, 2971–2976.
13. Beaulieu, P. L.; Hache, B.; von Moos, E. A. Practical oxone-mediated, high-throughput,
solution-phase synthesis of benzimidazolesfrom 1,2-phenylenediamines and aldehydes and
its application to preparative-scale synthesis. Synthesis 2003, 11, 1683–1692.
14. Austen, S. C.; Kane, J. M. A short synthesis of the PARP inhibitor 2-(4-trifluoro
methylphenyl)benzimidazole-4-carboxamide. J. Heterocycl. Chem. 2001, 38, 979–980.
15. Lombardy, R. L.; Tanious, F. A.; Ramachandran, K.; Tidwell, R. R.; Wilson, W. D.
Synthesis and DNA interactions of benzimidazole dications which have activity against
opportunistic infections. J. Med. Chem. 1996, 39, 1452–1462.